|
Suggested Usage: As a dietary supplement, take 1 Vcap® 1 to 3 times daily, preferably with meals. Consider taking this product in combination with NOW® Pycnogenol® and Tru-E BioComplex™.
Other Ingredients: Cellulose (capsule), Cellulose, Stearic Acid (vegetable source), Magnesium Stearate (vegetable source) and Silica. Vegetarian/Vegan Product.
Contains no: sugar, salt, starch, yeast, wheat, gluten, soy, milk, egg or shellfish.
Disclaimers: *These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
Some scientific evidence suggests that consumption of antioxidant vitamins may reduce the risk of certain forms of cancer. However, the FDA has determined that this evidence is limited and not conclusive.
**This product does not contain Ester-C®. Ester-C® is a licensed trademark of The Ester C Company.
NOW® AlphaSorb-C™ Revolutionizes Vitamin C Uptake and Bioavailability
Jayson Kroner
NOW® AlphaSorb-C™ is a patent-pending formulation that combines the benefits of buffered vitamin C (ascorbate) with other antioxidants to create a product that specifically enhances ascorbate absorption, especially via the important glucose transport pathways. This makes AlphaSorb-C™ uniquely beneficial to the many millions of people with insulin resistance, or poor insulin sensitivity, who are prone to have poor ascorbate status, as well as for everyone seeking to improve vitamin C uptake into the bloodstream and cells. AlphaSorb-C™ is a nature-identical formulation designed to provide a more advanced replacement for the popular types of vitamin C developed years ago. It is available in a non-acidic, gentle form.
The decision to make these product advancements was based on a number of factors. Ultimately, the most innovative new formulas are being brought to the market as a result of ongoing research and advanced technology. Much has been learned about how vitamin C functions within the body, as well as which conditions provide the most optimal environment for its absorption and utilization. Over the past two years, NOW researchers closely monitored these findings in order to develop a formula that would set new standards for the efficacy of vitamin C and function-boosting co-factors.
One of the most significant findings involves the unique absorption abilities of threonic acid – a metabolite of ascorbic acid. An article published in the October 2007 Medical Science Monitor provided some of the most convincing evidence of the compound’s unique absorption abilities. A double-blind, placebo-controlled clinical study concluded that threonic acid had two very beneficial characteristics, First, it was shown to increase the amount of vitamin C that it is taken up by the immune system’s T-cells. Additionally, threonic acid was shown to increase vitamin C’s overall potency within the cells.
Based on these clinical studies and other scientific information, many loyal vitamin C users are now turning to threonic acid-containing formulas as a potent source of cellular protection. These findings, coupled with growing public interest in the potential of vitamin C metabolites, is what ultimately inspired NOW to develop AlphaSorb-C™. Realizing that absorption and utilization of vitamin C were key benefits that had to be provided by any new formulation, a theory was developed suggesting that vitamin C could be transported via active glucose transport pathways. This theory was found to be valid, and it was determined that said transport mechanism could be enhanced through proper formulation.
Human cell laboratory work demonstrated the benefits of AlphaSorb-C™ over ascorbic acid and a United States patent was applied for, specifically for the purpose of recognizing the compound’s unique mechanism of action. The efficacy of AlphaSorb-C™ is based on the unique combination of a non-acidic vitamin C plus certain metabolites, notably threonic acid and alpha lipoic acid.
The known benefits of non-acidic vitamin C and metabolites are combined with substances that stimulate vitamin C transport into cells, enhancing absorption into both the bloodstream and immune cells, while stimulating utilization by immune cells. Additionally, because of the ability of AlphaSorb-C™ to enhance vitamin C absorption via glucose transport channels, it is an ideal and suitable source of vitamin C for diabetics and those with blood sugar imbalances; individuals who traditionally struggle when it comes to maintaining healthy vitamin C levels.
Studies have determined that alpha lipoic acid may enhance the body’s ability to better utilize vitamin C in other ways, such as enhancing absorption through glucose pathways into cells, thus stimulating utilization in repair and protection activities.* Finally, this innovative new nature-identical vitamin C formula from NOW is 100% vegetarian, and has been enhanced with synergistic bioflavonoids to ensure that its active constituents are well-absorbed and highly effective. NOW® AlphaSorb-C™ is the culmination of ongoing advanced scientific research, and NOW’s dedication to improve vitamin C on a worldwide scale.
References
1. Weeks BS, Perez PP. Absorption rates and free radical scavenging values of vitamin C-lipid metabolites in human lymphoblastic cells. Med Sci Monitor. 2007 Oct; 13(10):BR205-10.
2. Internal Study, NOW Foods, 2007
3. Rowe DJ, Ko S, Tom XM, Silverstein SJ, Richards DW. Enhanced production of mineralized nodules and collagenous proteins in vitro by calcium ascorbate supplemented with vitamin C metabolites. Jour Periodontal. 1999 Sep;70(9):992-9
4. Constantinescu A, Tritschler H, Packer L. Alpha-Lipoic acid protects against hemolysis of human erythrocytes induced by peroxyl radicals. Biochem Mol Biol Int. 1994 Jul;33(4):669-79.
5. U.S. Patent Application: 1, Serial #11,877,230
* These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
|
Add First Review
